FOLFOX-4
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FOLFOX-4, covering 2011-06-14 to 2014-11-26. Get the full timeline:
Most recent: Clinical Trial Update: FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer [Phase 3]